Company Overview and News

9
AVEO Pharmaceuticals: An Update On This ~$3 Oncology Concern

2018-07-11 seekingalpha
We look at the progress the company has made and what may lie ahead for it and its stock.
AVEO SD

10
UPDATE 1-SandRidge draws interest from more bidders, including Midstates

2018-06-29 reuters
June 29 (Reuters) - SandRidge Energy Inc has been approached by 26 potential bidders for a buyout of the company or some of its assets, the U.S. shale oil producer said on Friday, days after activist investor Carl Icahn took control of its board.
SDOCQ SDRPQ MPO MPOYQ SDRXP SD SDRXQ

6
Sandridge To Explore Strategic Options, Including Sale

2018-06-29 rigzone
June 29 (Reuters) - U.S. shale oil producer SandRidge Energy Inc said on Friday it plans a strategic review of its business that could include a sale of the company or some of its assets.
SDOCQ SDRPQ SDRXP SD SDRXQ

68
SandRidge Energy: A Bankruptcy Reorg With A Catalyst And 100% Upside

2018-06-26 seekingalpha
Extremely attractive valuation, $725 million PDP PV-10 strip, $1,009 million PV-10 proved, versus roughly a $550 million market cap.
SDOCQ CHK SRCI SDRPQ BCEI SDRXP SD SDRXQ

6
Carl Icahn Won't Bid for SandRidge After Winning Control of Board - Bloomberg

2018-06-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SDOCQ SDRPQ SDRXP SD SDRXQ

0
SD / Sandridge Energy Inc. 8-K (Current Report)

2018-06-25 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SD

0
SD / Sandridge Energy Inc. / ICAHN CARL C - null (Activist Investment)

2018-06-25 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 S
SD

3
SD / Sandridge Energy Inc. / ICAHN CARL C - null (Activist Investment)

2018-06-25 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 S
SD

0
June 22 Natural Gas Weekly: Weather Pushed The Price Up And Weather Must Pull It Down

2018-06-24 seekingalpha
This report covers the week ending June 22, 2018. Daily data for June 16 to May 21 is estimated. Daily data for June 22 is forecast.
SD

669
Westlake Chemical Sees Hammer Chart Pattern: Time to Buy?

2018-06-21 zacks
Westlake Chemical Corporation (WLK - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because WLK recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
SDOCQ BBW WLK SDRPQ AMD SDRXP MPC SD SDRXQ

670
Five Prime Therapeutics Sees Hammer Chart Pattern: Time to Buy?

2018-06-21 zacks
Five Prime Therapeutics, Inc. (FPRX - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because FPRX recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
SDOCQ BBW SDRPQ AMD FPRX SDRXP MPC SD SDRXQ

695
Globalstar Sees Hammer Chart Pattern: Time to Buy?

2018-06-21 zacks
Globalstar, Inc. (GSAT - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because GSAT recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
SDOCQ GSAT BBW SDRPQ AMD SDRXP MPC SD SDRXQ

0
SD / Sandridge Energy Inc. / ICAHN CARL C - null (Activist Investment)

2018-06-20 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 S
SD

3
SD / Sandridge Energy Inc. / ICAHN CARL C - null (Activist Investment)

2018-06-20 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 S
SD

11
SandRidge Energy (SD) Looks Good: Stock Adds 7.5% in Session

2018-06-20 zacks
SandRidge Energy, Inc. (SD - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 13.9% in the past one-month time frame.
SDOCQ SDRPQ OXY SDRXP SD SDRXQ

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Silicon Investor Message Boards

This table lists all message boards related to SD / Sandridge Energy Inc. on message board site Silicon Investor.

Shopify Inc (SHOP: NASDAQ) SHOP.TO PSDV - pSivida Limited
Manmade Global Warming, A hoax? A Scam? or a Doomsday Cult? Tuesday Morning
Lam Research (LRCX, NASDAQ): To the Insiders Aixtron AIXG now listed on the NASDAQ after GGNS merger
Ancestry.com NASD: ACOM Cardiac Science Inc. DFIB (NASDAQ)
seadrill SDRL Take Two Interactive Software (TTWO: Nasdaq) taking off!
CUSIP: 80007P869